0000000000337278

AUTHOR

Giuseppe Sandro Mela

showing 8 related works from this author

Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test.

1999

The 13C-urea breath test (UBT) is a sensitive and noninvasive method to diagnose Helicobacter pylori infection, but mass spectrometry (IRMS) is very expensive. The aims of this study were to compare the new low-priced infrared spectroscopy with IRMS in detecting the infection and to assess the influence of feeding on test accuracy.One hundred thirty-four patients with dyspeptic symptoms were recruited. Of these, 74 were infected and 60 uninfected on the basis of both CLO-test and histology. A subgroup of 37 patients (22 H. pylori-positive and 15 H. pylori-negative) was studied under fasting and nonfasting conditions on two different days. Duplicate breath samples were analyzed with two IRMS…

MalePathologymedicine.medical_specialtySpectrophotometry InfraredAnalytical chemistryInfrared spectroscopyMass spectrometrySensitivity and SpecificityMass Spectrometry13C urea breath testHelicobacter Infectionschemistry.chemical_compoundmedicineHumansUreaIsotope-ratio mass spectrometryDyspepsiaBreath testCarbon IsotopesHepatologymedicine.diagnostic_testIsotopeHelicobacter pyloribusiness.industryGastroenterologyMiddle AgedchemistryBreath TestsDuodenal UlcerUreaFemalebusiness
researchProduct

H2 antagonist and omeprazole nonresponders.

1991

Malemedicine.medical_specialtyPhysiologybusiness.industrymedicine.medical_treatmentGastroenterologyMiddle AgedHepatologyGastroenterologyH2 antagonistText miningTransplant surgeryHistamine H2 AntagonistsDuodenal UlcerInternal medicinemedicineHumansFemalebusinessOmeprazoleOmeprazolemedicine.drug
researchProduct

Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine

1996

There is much experimental work on the occurrence of tolerance to the antisecretory effect of H2-receptor antagonists in healthy subjects, while data on its development in patients with duodenal ulcer are poor and conflicting. Moreover, this phenomenon has not been studied previously with 24 h gastric pH-metry in patients with active duodenal ulcer. For these reasons, we carried out a prospective pharmacodynamic investigation in 48 patients with endoscopically proven duodenal ulcer using the well-established once daily dosing schedule of H2 blockers. They were studied by means of 24 h continuous endoluminal pH-metry which was performed before, on d1 and d28 after receiving an oral bedtime d…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentRanitidineBedtimeGastroenterologyH2 antagonistRanitidinePiperidinesHistamine H2 receptorOral administrationDrug toleranceInternal medicinemedicineHumansSingle-Blind MethodPharmacology (medical)Prospective StudiesPharmacologyAnalysis of Variancebusiness.industryDrug ToleranceGastric Acidity DeterminationHydrogen-Ion ConcentrationMiddle Agedmedicine.anatomical_structureHistamine H2 AntagonistsDuodenal UlcerPharmacodynamicsDuodenumFemalebusinessmedicine.drugFundamental & Clinical Pharmacology
researchProduct

Duodenal ulcer healing drugs

1994

Duodenal ulcermedicine.medical_specialtyText miningbusiness.industryInternal medicinemedicineGeneral MedicinebusinessGastroenterologyThe Lancet
researchProduct

A Comparison of Five Maintenance Therapies for Reflux Esophagitis

1995

Patients with reflux esophagitis have a high rate of relapse within one year after therapy is discontinued.We enrolled 175 adults with endoscopy-confirmed reflux esophagitis in a prospective study comparing five maintenance therapies. All the patients were initially treated with omeprazole (40 mg orally once a day) for four to eight weeks, and healing was confirmed by endoscopy. Participants were then stratified according to their initial grade of esophagitis and randomly assigned to 12 months of treatment with one of the following: cisapride (10 mg three times a day), ranitidine (150 mg three times a day), omeprazole (20 mg per day), ranitidine plus cisapride (10 mg three times a day), or …

AdultMalemedicine.medical_specialtyRanitidineSeverity of Illness IndexGastroenterologyDisease-Free SurvivalRanitidinePiperidinesRecurrenceInternal medicinemedicineHumansSingle-Blind MethodProspective StudiesReflux esophagitisProspective cohort studyEsophagitis PepticOmeprazoleCisapridemedicine.diagnostic_testEsophageal diseasebusiness.industryGeneral MedicineMiddle AgedAnti-Ulcer Agentsmedicine.diseaseSurgeryEndoscopyTreatment OutcomeHistamine H2 AntagonistsCisaprideDrug Therapy CombinationFemaleEsophagoscopybusinessEsophagitisOmeprazolemedicine.drugNew England Journal of Medicine
researchProduct

Time pattern of gastric acidity in Barrett's esophagus.

1996

Increased gastroesophageal acid reflux is frequently found in patients with Barrett's esophagus, and it has been hypothesized that gastric acid hypersecretion could be an important factor aggravating the exposure of esophageal mucosa to acid and then contributing to the development of this disorder. The aim of the present study was to assess whether the circadian pattern of gastric acidity differs between refluxer patients with and without Barrett's esophagus and normal subjects. Continuous 24-hr gastric pH monitoring was performed in 119 healthy volunteers, 20 patients with Barrett's esophagus, 37 patients with moderate and 10 patients with severe reflux esophagitis without Barrett's esoph…

Malemedicine.medical_specialtyPhysiologyPopulationGastroenterologyGastric AcidBarrett EsophagusInternal medicinemedicineHumansEsophagusReflux esophagitiseducationEsophagitis PepticMonitoring Physiologiceducation.field_of_studybusiness.industryEsophageal diseaseStomachdigestive oral and skin physiologyGastroenterologyRefluxGastric Acidity DeterminationMiddle Agedmedicine.diseasedigestive system diseasesCircadian Rhythmmedicine.anatomical_structureBarrett's esophagusGastric acidFemalebusinessDigestive diseases and sciences
researchProduct

Helicobacter pylori eradication and reinfection

1995

biologybusiness.industryMedicineGeneral MedicineHelicobacter pyloribusinessbiology.organism_classificationVirologyThe Lancet
researchProduct

Optimal dose of omeprazole in duodenal ulcer

1993

Duodenal ulcermedicine.medical_specialtyHepatologybusiness.industryInternal medicineGastroenterologyMedicinebusinessGastroenterologyOmeprazolemedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct